CD8A and neoplasm: Meanwhile, CD8+ T-cell trafficking into the tumor site may be blocked by the prominent desmoplastic TME, which also causes vascular dysfunction to hinder therapeutic antibody delivery, resulting in an immunosuppressive microenvironment [46–48].